NASDAQ:HYPR Hyperfine (HYPR) Stock Price, News & Analysis → The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad) Free HYPR Stock Alerts $0.83 +0.02 (+2.47%) (As of 05:21 PM ET) Add Compare Share Share Today's Range$0.82▼$0.9050-Day Range$0.81▼$1.2552-Week Range$0.80▼$3.28Volume56,505 shsAverage Volume69,966 shsMarket Capitalization$59.72 millionP/E RatioN/ADividend YieldN/APrice Target$2.12 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Hyperfine alerts: Email Address Hyperfine MarketRank™ Stock AnalysisAnalyst RatingHold2.33 Rating ScoreUpside/Downside155.0% Upside$2.12 Price TargetShort InterestBearish2.81% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.00Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.53) to ($0.50) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.06 out of 5 starsMedical Sector775th out of 911 stocksElectromedical Equipment Industry16th out of 19 stocks 3.2 Analyst's Opinion Consensus RatingHyperfine has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageHyperfine has only been the subject of 1 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted2.81% of the float of Hyperfine has been sold short.Short Interest Ratio / Days to CoverHyperfine has a short interest ratio ("days to cover") of 18.3, which indicates bearish sentiment.Change versus previous monthShort interest in Hyperfine has recently increased by 3.20%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldHyperfine does not currently pay a dividend.Dividend GrowthHyperfine does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for HYPR. Previous Next 0.6 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 2 news articles for Hyperfine this week, compared to 1 article on an average week.MarketBeat Follows3 people have added Hyperfine to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Hyperfine insiders have not sold or bought any company stock.Percentage Held by Insiders26.50% of the stock of Hyperfine is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 15.03% of the stock of Hyperfine is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Hyperfine are expected to grow in the coming year, from ($0.53) to ($0.50) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Hyperfine is -1.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Hyperfine is -1.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHyperfine has a P/B Ratio of 0.71. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About Hyperfine Stock (NASDAQ:HYPR)Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.Read More HYPR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HYPR Stock News HeadlinesApril 17, 2024 | msn.comHyperfine (HYPR) Price Target Decreased by 6.02% to 1.33April 17, 2024 | businesswire.comLeading Institutions Enroll First Alzheimer's Patients Receiving Amyloid-Targeting Therapy in CARE PMR StudyApril 19, 2024 | Gold Safe Exchange (Ad)The “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.March 23, 2024 | markets.businessinsider.comChallenges Ahead: Revising Hyperfine’s Outlook Amid Lower-than-Expected Financial PerformanceMarch 22, 2024 | msn.comHyperfine, Inc. (NASDAQ:HYPR) Q4 2023 Earnings Call TranscriptMarch 21, 2024 | investorplace.comHYPR Stock Earnings: Hyperfine Beats EPS, Misses Revenue for Q4 2023March 21, 2024 | benzinga.comRecap: Hyperfine Q4 EarningsMarch 21, 2024 | globenewswire.comHyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial ResultsApril 19, 2024 | Gold Safe Exchange (Ad)The “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.March 12, 2024 | finance.yahoo.comHyperfine, Inc. Collaborates with King’s College London to Demonstrate the Swoop® System and UNITY Project to The Princess RoyalMarch 12, 2024 | businesswire.comHyperfine, Inc. Collaborates with King's College London to Demonstrate the Swoop® System and UNITY Project to The Princess RoyalMarch 7, 2024 | businesswire.comHyperfine, Inc. to Announce Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024February 28, 2024 | finance.yahoo.comHyperfine, Inc. to Present at the Oppenheimer 34th Annual Healthcare ConferenceFebruary 24, 2024 | morningstar.comHyperfine Inc Class A HYPRFebruary 21, 2024 | businesswire.comHyperfine, Inc. Announces Collaboration with Athletic Heart to Provide Vital Brain Health Imaging for Former Professional AthletesFebruary 11, 2024 | investing.comHYPR/USD - Hypr Network US DollarJanuary 9, 2024 | finance.yahoo.comHyperfine, Inc. Launches AI-powered Brain Imaging Software for Enhanced Image Quality and Ease of UseDecember 1, 2023 | benzinga.comHyperfine Stock (NASDAQ:HYPR) Earnings Dates and Earning CallsDecember 1, 2023 | markets.businessinsider.comMaintaining Hold on Hyperfine: Weighing Swoop MRI’s Market Entry Challenges Against Future Growth ProspectsNovember 30, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Hyperfine (HYPR) and Johnson & Johnson (JNJ)November 30, 2023 | benzinga.comHyperfine Stock (NASDAQ:HYPR) Dividends: History, Yield and DatesNovember 30, 2023 | msn.comJefferies starts Hyperfine at hold, says company still in early commercial stageNovember 30, 2023 | msn.comJefferies Initiates Coverage of Hyperfine Inc - (HYPR) with Hold RecommendationNovember 20, 2023 | finance.yahoo.comHyperfine, Inc. Announces Presentations on Clinical Advancements at RSNA 2023November 16, 2023 | finance.yahoo.comHyperfine, Inc. to Present at the Piper Sandler 35th Annual Healthcare ConferenceNovember 12, 2023 | finance.yahoo.comHyperfine, Inc. (NASDAQ:HYPR) Q3 2023 Earnings Call TranscriptNovember 9, 2023 | finance.yahoo.comHyperfine, Inc. Reports Third Quarter 2023 Financial ResultsSee More Headlines Receive HYPR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hyperfine and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/21/2024Today4/19/2024Next Earnings (Estimated)5/09/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolNASDAQ:HYPR CUSIPN/A CIK1833769 Webhyperfine.io Phone866-796-6767FaxN/AEmployees131Year FoundedN/APrice Target and Rating Average Stock Price Target$2.12 High Stock Price Target$3.50 Low Stock Price Target$1.25 Potential Upside/Downside+140.5%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($0.62) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-44,240,000.00 Net Margins-401.00% Pretax Margin-401.00% Return on Equity-44.89% Return on Assets-40.96% Debt Debt-to-Equity RatioN/A Current Ratio10.14 Quick Ratio9.39 Sales & Book Value Annual Sales$11.03 million Price / Sales5.74 Cash FlowN/A Price / Cash FlowN/A Book Value$1.17 per share Price / Book0.75Miscellaneous Outstanding Shares71,950,000Free Float52,883,000Market Cap$63.32 million OptionableOptionable Beta0.75 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. R. Scott Huennekens CPA (Age 60)M.B.A., Executive Chairman Comp: $1.29MMs. Maria Sainz (Age 58)CEO, President & Director Comp: $340.24kDr. Jonathan M. Rothberg Ph.D. (Age 60)Founder & Vice Chairman Comp: $51.37kMr. Brett Hale (Age 50)Chief Administrative Officer, CFO, Chief Compliance Officer, Treasurer & Corporate Secretary Mr. Chip Truwit FACRM.D., Vice President of Scientific AffairsKey CompetitorsVivani MedicalNASDAQ:VANIFONARNASDAQ:FONROutset MedicalNASDAQ:OMPrecision OpticsNASDAQ:POCIelectroCoreNASDAQ:ECORView All CompetitorsInsiders & InstitutionsVirtu Financial LLCBought 75,224 shares on 2/26/2024Ownership: 0.105%Citadel Advisors LLCBought 600 shares on 2/15/2024Ownership: 0.000%Journey Strategic Wealth LLCBought 74,929 shares on 2/9/2024Ownership: 0.105%Thomas TeisseyreSold 2,655 sharesTotal: $3,345.30 ($1.26/share)Khan SiddiquiSold 1,735 sharesTotal: $2,168.75 ($1.25/share)View All Insider TransactionsView All Institutional Transactions HYPR Stock Analysis - Frequently Asked Questions Should I buy or sell Hyperfine stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Hyperfine in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" HYPR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HYPR, but not buy additional shares or sell existing shares. View HYPR analyst ratings or view top-rated stocks. What is Hyperfine's stock price target for 2024? 3 Wall Street research analysts have issued twelve-month target prices for Hyperfine's shares. Their HYPR share price targets range from $1.25 to $3.50. On average, they predict the company's share price to reach $2.12 in the next twelve months. This suggests a possible upside of 155.0% from the stock's current price. View analysts price targets for HYPR or view top-rated stocks among Wall Street analysts. How have HYPR shares performed in 2024? Hyperfine's stock was trading at $1.12 at the beginning of 2024. Since then, HYPR stock has decreased by 25.9% and is now trading at $0.83. View the best growth stocks for 2024 here. When is Hyperfine's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our HYPR earnings forecast. How were Hyperfine's earnings last quarter? Hyperfine, Inc. (NASDAQ:HYPR) announced its quarterly earnings data on Thursday, March, 21st. The company reported ($0.15) EPS for the quarter, beating analysts' consensus estimates of ($0.17) by $0.02. The business earned $2.69 million during the quarter, compared to analysts' expectations of $3.66 million. Hyperfine had a negative trailing twelve-month return on equity of 44.89% and a negative net margin of 401.00%. What guidance has Hyperfine issued on next quarter's earnings? Hyperfine updated its FY 2024 earnings guidance on Thursday, March, 21st. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $12.0 million-$15.0 million, compared to the consensus revenue estimate of $18.4 million. How do I buy shares of Hyperfine? Shares of HYPR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:HYPR) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingHow Biden has already won 2024Porter & CompanyUrgent alert: open this for a huge profit potentialTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hyperfine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.